Integrated clinical genomic analysis reveals xenobiotic metabolic genes are downregulated in meningiomas of current smokers.
Meningioma
Smoking
UGT2A1
UGT2A2
Xenobiotic metabolism
Journal
Journal of neuro-oncology
ISSN: 1573-7373
Titre abrégé: J Neurooncol
Pays: United States
ID NLM: 8309335
Informations de publication
Date de publication:
Jun 2023
Jun 2023
Historique:
received:
27
04
2023
accepted:
30
05
2023
medline:
7
7
2023
pubmed:
15
6
2023
entrez:
15
6
2023
Statut:
ppublish
Résumé
Meningiomas are the most common primary intracranial tumor. Recently, various genetic classification systems for meningioma have been described. We sought to identify clinical drivers of different molecular changes in meningioma. As such, clinical and genomic consequences of smoking in patients with meningiomas remain unexplored. 88 tumor samples were analyzed in this study. Whole exome sequencing (WES) was used to assess somatic mutation burden. RNA sequencing data was used to identify differentially expressed genes (DEG) and genes sets (GSEA). Fifty-seven patients had no history of smoking, twenty-two were past smokers, and nine were current smokers. The clinical data showed no major differences in natural history across smoking status. WES revealed absence of AKT1 mutation rate in current or past smokers compared to non-smokers (p = 0.046). Current smokers had increased mutation rate in NOTCH2 compared to past and never smokers (p < 0.05). Mutational signature from current and past smokers showed disrupted DNA mismatch repair (cosine-similarity = 0.759 and 0.783). DEG analysis revealed the xenobiotic metabolic genes UGT2A1 and UGT2A2 were both significantly downregulated in current smokers compared to past (Log2FC = - 3.97, padj = 0.0347 and Log2FC = - 4.18, padj = 0.0304) and never smokers (Log2FC = - 3.86, padj = 0.0235 and Log2FC = - 4.20, padj = 0.0149). GSEA analysis of current smokers showed downregulation of xenobiotic metabolism and enrichment for G2M checkpoint, E2F targets, and mitotic spindle compared to past and never smokers (FDR < 25% each). In this study, we conducted a comparative analysis of meningioma patients based on their smoking history, examining both their clinical trajectories and molecular changes. Meningiomas from current smokers were more likely to harbor NOTCH2 mutations, and AKT1 mutations were absent in current or past smokers. Moreover, both current and past smokers exhibited a mutational signature associated with DNA mismatch repair. Meningiomas from current smokers demonstrate downregulation of xenobiotic metabolic enzymes UGT2A1 and UGT2A2, which are downregulated in other smoking related cancers. Furthermore, current smokers exhibited downregulation xenobiotic metabolic gene sets, as well as enrichment in gene sets related to mitotic spindle, E2F targets, and G2M checkpoint, which are hallmark pathways involved in cell division and DNA replication control. In aggregate, our results demonstrate novel alterations in meningioma molecular biology in response to systemic carcinogens.
Identifiants
pubmed: 37318677
doi: 10.1007/s11060-023-04359-7
pii: 10.1007/s11060-023-04359-7
doi:
Substances chimiques
Xenobiotics
0
UGT2A1 protein, human
EC 2.4.1.17
Glucuronosyltransferase
EC 2.4.1.17
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
397-405Subventions
Organisme : NINDS NIH HHS
ID : K08NS102474
Pays : United States
Organisme : NINDS NIH HHS
ID : K08NS102474
Pays : United States
Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Wiemels J, Wrensch M, Claus EB (2010) Epidemiology and etiology of meningioma. J Neurooncol 99(3):307–314
pubmed: 20821343
pmcid: 2945461
doi: 10.1007/s11060-010-0386-3
Jääskeläinen J (1986) Seemingly complete removal of histologically benign intracranial meningioma: late recurrence rate and factors predicting recurrence in 657 patients. A multivariate analysis Surg Neurol 26(5):461–469
pubmed: 3764651
Bayley, J.C.t., et al., Multiple approaches converge on three biological subtypes of meningioma and extract new insights from published studies. Sci Adv, 2022. 8(5): p. eabm6247.
Patel AJ et al (2019) Molecular profiling predicts meningioma recurrence and reveals loss of DREAM complex repression in aggressive tumors. Proc Natl Acad Sci U S A 116(43):21715–21726
pubmed: 31591222
pmcid: 6815170
doi: 10.1073/pnas.1912858116
Choudhury A et al (2022) Meningioma DNA methylation groups identify biological drivers and therapeutic vulnerabilities. Nat Genet 54(5):649–659
pubmed: 35534562
pmcid: 9374001
doi: 10.1038/s41588-022-01061-8
Nassiri F et al (2021) A clinically applicable integrative molecular classification of meningiomas. Nature 597(7874):119–125
pubmed: 34433969
doi: 10.1038/s41586-021-03850-3
Louis DN et al (2021) The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro Oncol 23(8):1231–1251
pubmed: 34185076
pmcid: 8328013
doi: 10.1093/neuonc/noab106
Lee YS, Lee YS (2020) Molecular characteristics of meningiomas. J Pathol Transl Med 54(1):45–63
pubmed: 31964111
pmcid: 6986967
doi: 10.4132/jptm.2019.11.05
Lee S et al (2019) The role of Merlin/NF2 loss in meningioma biology. Cancers (Basel) 11(11):1633
pubmed: 31652973
doi: 10.3390/cancers11111633
Khan AB et al (2023) Even heterozygous loss of CDKN2A/B greatly accelerates recurrence in aggressive meningioma. Acta Neuropathol 145(4):501–503
pubmed: 36729132
doi: 10.1007/s00401-023-02543-7
Jansen M et al (2012) Gain of chromosome arm 1q in atypical meningioma correlates with shorter progression-free survival. Neuropathol Appl Neurobiol 38(2):213–219
pubmed: 21988727
pmcid: 3563294
doi: 10.1111/j.1365-2990.2011.01222.x
Agnihotri S et al (2017) Therapeutic radiation for childhood cancer drives structural aberrations of NF2 in meningiomas. Nat Commun 8(1):186
pubmed: 28775249
pmcid: 5543118
doi: 10.1038/s41467-017-00174-7
Khan AB et al (2020) Identification of novel fusion transcripts in meningioma. J Neurooncol 149(2):219–230
pubmed: 32949309
pmcid: 7553203
doi: 10.1007/s11060-020-03599-1
Zhang ZF et al (2000) Environmental tobacco smoking, mutagen sensitivity, and head and neck squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 9(10):1043–1049
pubmed: 11045786
Hussain A et al (2019) Neoplastic pathogenesis associated with cigarette carcinogens. Cureus 11(1):e3955
pubmed: 30956908
pmcid: 6436676
Ma Y, Li MD (2017) Establishment of a strong link between smoking and cancer pathogenesis through DNA methylation analysis. Sci Rep 7(1):1811
pubmed: 28500316
pmcid: 5431893
doi: 10.1038/s41598-017-01856-4
Phillips LE et al (2005) Active and passive cigarette smoking and risk of intracranial meningioma. Neuroepidemiology 24(3):117–122
pubmed: 15637448
doi: 10.1159/000082998
Claus EB et al (2012) Cigarette smoking and risk of meningioma: the effect of gender. Cancer Epidemiol Biomarkers Prev 21(6):943–950
pubmed: 22473761
pmcid: 3613227
doi: 10.1158/1055-9965.EPI-11-1059
Fan Z et al (2013) Smoking and risk of meningioma: a meta-analysis. Cancer Epidemiol 37(1):39–45
pubmed: 23102704
doi: 10.1016/j.canep.2012.09.004
Vida S et al (2014) Brain tumours and cigarette smoking: analysis of the INTERPHONE Canada case-control study. Environ Health 13:55
pubmed: 24972852
pmcid: 4088305
doi: 10.1186/1476-069X-13-55
Omiecinski CJ et al (2011) Xenobiotic metabolism, disposition, and regulation by receptors: from biochemical phenomenon to predictors of major toxicities. Toxicol Sci 120:S49-75
pubmed: 21059794
doi: 10.1093/toxsci/kfq338
Banerjee J et al (2009) Radiation-induced meningiomas: a shadow in the success story of childhood leukemia. Neuro Oncol 11(5):543–549
pubmed: 19179425
pmcid: 2765343
doi: 10.1215/15228517-2008-122
Love MI, Huber W, Anders S (2014) Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol 15(12):550
pubmed: 25516281
pmcid: 4302049
doi: 10.1186/s13059-014-0550-8
Wang L et al (2015) Genomic profiling of Sezary syndrome identifies alterations of key T cell signaling and differentiation genes. Nat Genet 47(12):1426–1434
pubmed: 26551670
pmcid: 4829974
doi: 10.1038/ng.3444
Mayakonda A et al (2018) Maftools: efficient and comprehensive analysis of somatic variants in cancer. Genome Res 28(11):1747–1756
pubmed: 30341162
pmcid: 6211645
doi: 10.1101/gr.239244.118
Subramanian A et al (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102(43):15545–15550
pubmed: 16199517
pmcid: 1239896
doi: 10.1073/pnas.0506580102
Mootha VK et al (2003) PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 34(3):267–273
pubmed: 12808457
doi: 10.1038/ng1180
Li L, Feng Q, Wang X (2020) PreMSIm: An R package for predicting microsatellite instability from the expression profiling of a gene panel in cancer. Comput Struct Biotechnol J 18:668–675
pubmed: 32257050
pmcid: 7113609
doi: 10.1016/j.csbj.2020.03.007
Alexandrov LB et al (2013) Signatures of mutational processes in human cancer. Nature 500(7463):415–421
pubmed: 23945592
pmcid: 3776390
doi: 10.1038/nature12477
The 2004 United States Surgeon General's Report: The Health Consequences of Smoking. N S W Public Health Bull, 2004. 15(5–6): p. 107.
Hiscock R et al (2012) Socioeconomic status and smoking: a review. Ann N Y Acad Sci 1248:107–123
pubmed: 22092035
doi: 10.1111/j.1749-6632.2011.06202.x
Jackson HN et al (2022) Racial and socioeconomic disparities in patients with meningioma: a retrospective cohort study. Neurosurgery 90(1):114–123
pubmed: 34982878
doi: 10.1227/NEU.0000000000001751
Clark VE et al (2013) Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO. Science 339(6123):1077–1080
pubmed: 23348505
pmcid: 4808587
doi: 10.1126/science.1233009
Christiaans I et al (2011) Germline SMARCB1 mutation and somatic NF2 mutations in familial multiple meningiomas. J Med Genet 48(2):93–97
pubmed: 20930055
doi: 10.1136/jmg.2010.082420
Michelsen B et al (1990) HLA heterozygosity in insulin-dependent diabetes is most frequent at the DQ locus. Scand J Immunol 31(4):405–413
pubmed: 2333466
doi: 10.1111/j.1365-3083.1990.tb02786.x
Weller M et al (2017) Durable control of metastatic AKT1-Mutant WHO grade 1 meningothelial meningioma by the AKT inhibitor, AZD5363. J Natl Cancer Inst 109(3):1–4
pubmed: 28376212
doi: 10.1093/jnci/djw320
Li W et al (2017) Cigarette smoke enhances initiation and progression of lung cancer by mutating Notch1/2 and dysregulating downstream signaling molecules. Oncotarget 8(70):115128–115139
pubmed: 29383147
pmcid: 5777759
doi: 10.18632/oncotarget.22924
Baia GS et al (2008) Notch activation is associated with tetraploidy and enhanced chromosomal instability in meningiomas. Neoplasia 10(6):604–612
pubmed: 18516297
pmcid: 2386545
doi: 10.1593/neo.08356
Yang P et al (2000) Higher risk of mismatch repair-deficient colorectal cancer in alpha(1)-antitrypsin deficiency carriers and cigarette smokers. Mol Genet Metab 71(4):639–645
pubmed: 11136557
doi: 10.1006/mgme.2000.3089
Slattery ML et al (2000) Associations between cigarette smoking, lifestyle factors, and microsatellite instability in colon tumors. J Natl Cancer Inst 92(22):1831–1836
pubmed: 11078760
doi: 10.1093/jnci/92.22.1831
Nandi S et al (2006) Expression of DNA mismatch repair proteins in transformed non-Hodgkin’s lymphoma: relationship to smoking. Leuk Lymphoma 47(9):1806–1812
pubmed: 17064992
doi: 10.1080/10428190600652137
Mukherjee B et al (2014) Reduction of DNA mismatch repair protein expression in airway epithelial cells of premenopausal women chronically exposed to biomass smoke. Environ Sci Pollut Res Int 21(4):2826–2836
pubmed: 24146321
doi: 10.1007/s11356-013-2218-4
Doukas SG et al (2022) The effect of tobacco smoke N-Nitrosamines, NNK and NDEA, and nicotine, on DNA mismatch repair mechanism and miRNA markers, in hypopharyngeal squamous cell carcinoma: an in vivo model and clinical evidence. Curr Oncol 29(8):5531–5549
pubmed: 36005175
pmcid: 9406897
doi: 10.3390/curroncol29080437
Harth V et al (2008) Head and neck squamous-cell cancer and its association with polymorphic enzymes of xenobiotic metabolism and repair. J Toxicol Environ Health A 71(13–14):887–897
pubmed: 18569591
doi: 10.1080/15287390801988160
Rouissi K et al (2011) Smoking and polymorphisms in xenobiotic metabolism and DNA repair genes are additive risk factors affecting bladder cancer in Northern Tunisia. Pathol Oncol Res 17(4):879–886
pubmed: 21647780
doi: 10.1007/s12253-011-9398-3
Pande M et al (2010) Interactions between cigarette smoking and selected polymorphisms in xenobiotic metabolizing enzymes in risk for colorectal cancer: A case-only analysis. Mol Carcinog 49(11):974–980
pubmed: 20886582
pmcid: 3034292
doi: 10.1002/mc.20682
Berrandou T et al (2019) Association of breast cancer risk with polymorphisms in genes involved in the metabolism of xenobiotics and interaction with tobacco smoking: A gene-set analysis. Int J Cancer 144(8):1896–1908
pubmed: 30303517
doi: 10.1002/ijc.31917
Bushey RT, Lazarus P (2012) Identification and functional characterization of a novel UDP-glucuronosyltransferase 2A1 splice variant: potential importance in tobacco-related cancer susceptibility. J Pharmacol Exp Ther 343(3):712–724
pubmed: 22984225
pmcid: 3500542
doi: 10.1124/jpet.112.198770
Bushey RT, Dluzen DF, Lazarus P (2013) Importance of UDP-glucuronosyltransferases 2A2 and 2A3 in tobacco carcinogen metabolism. Drug Metab Dispos 41(1):170–179
pubmed: 23086198
pmcid: 3533432
doi: 10.1124/dmd.112.049171
Bushey RT et al (2011) Characterization of UDP-glucuronosyltransferase 2A1 (UGT2A1) variants and their potential role in tobacco carcinogenesis. Pharmacogenet Genomics 21(2):55–65
pubmed: 21164388
pmcid: 3019304
doi: 10.1097/FPC.0b013e328341db05
Thum T et al (2006) Expression of xenobiotic metabolizing enzymes in different lung compartments of smokers and nonsmokers. Environ Health Perspect 114(11):1655–1661
pubmed: 17107849
pmcid: 1665420
doi: 10.1289/ehp.8861
Hu DG et al (2021) The expression profiles and deregulation of UDP-Glycosyltransferase (UGT) genes in human cancers and their association with clinical outcomes. Cancers (Basel) 13(17):4491
pubmed: 34503303
doi: 10.3390/cancers13174491